Proposed Data Collections Submitted for Public Comment and Recommendations, 506-507 [2014-30889]
Download as PDF
<![CDATA[
506
Federal Register / Vol. 80, No. 3 / Tuesday, January 6, 2015 / Notices
Agreement No.: 201048–008.
Title: Lease and Operating Agreement
between Philadelphia Regional Port
Authority and Delaware River
Stevedores, Inc.
Parties: Philadelphia Regional Port
Authority and Delaware River
Stevedores, Inc.
Filing Party: Paul D. Coleman, Esq.;
Hoppel, Mayer & Coleman; 1050
Connecticut Avenue NW., Tenth Floor;
Washington, DC 20036.
Synopsis: The amendment allows for
the agreement on and procedures for the
dredging of berths to certain depths.
Dated: December 31, 2014.
By Order of the Federal Maritime
Commission.
Karen V. Gregory,
Secretary.
BILLING CODE 6210–01–P
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than January 30,
2015.
A. Federal Reserve Bank of Boston
(Richard Walker, Community Affairs
Jkt 235001
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
HIV Outpatient Study (HOPS)—
New—National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. To request more
information on the below proposed
project or to obtain a copy of the
information collection plan and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
Background and Brief Description
The Centers for Disease Control and
Prevention requests a three-year
approval for the HIV Outpatient Study
data collection activity. The HIV
Outpatient Study (HOPS) is a
prospective longitudinal cohort of HIVinfected outpatients at nine wellestablished private HIV care practices
and university-based U.S. clinics, in
Tampa, Florida; Washington, DC; Stony
Brook, New York; Chicago, Illinois;
Denver, Colorado; and Philadelphia,
Pennsylvania.
Clinical data are abstracted on
ongoing basis from the medical records
of adult HIV-infected HOPS study
participants, who also complete an
optional telephone/Web-based
behavioral assessment as part of their
annual clinic visit, which on average
takes about seven minutes. Before
enrolling in this study, all potential
study participants will undergo an
informed consent process (including
signing of a written informed consent)
which is estimated to take 15 minutes.
The core areas of HOPS research
extending through the present HIV
treatment era include (i) monitoring
death rates and causes of death, (ii)
characterizing the optimal patient
management strategies to reduce HIVrelated morbidity and mortality (e.g.,
effectiveness of antiretroviral therapies
and other clinical interventions), (iii)
monitoring of sexual and drug use
behaviors to inform Prevention with
Positives, and (iv) investigating
disparities in the HIV care continuum
by various demographic factors. In
recent years, the HOPS has been
[60 Day–15–15JX]
FEDERAL RESERVE SYSTEM
tkelley on DSK3SPTVN1PROD with NOTICES
[FR Doc. 2014–30926 Filed 1–5–15; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 6730–01–P
20:28 Jan 05, 2015
Board of Governors of the Federal Reserve
System, December 31, 2014.
Robert deV. Frierson,
Secretary of the Board.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–30952 Filed 1–5–15; 8:45 am]
VerDate Sep<11>2014
Officer) 600 Atlantic Avenue, Boston,
Massachusetts 02210–2204:
1. Berkshire Hills Bancorp, Inc.,
Pittsfield, Massachusetts; to acquire and
merge with Hampden Bank, and thereby
indirectly acquire Hampden Bancorp,
Inc., both in Springfield, Massachusetts.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
E:\FR\FM\06JAN1.SGM
06JAN1
507
Federal Register / Vol. 80, No. 3 / Tuesday, January 6, 2015 / Notices
instrumental in bringing attention to
emerging issues in chronic HIV
infection with actionable opportunities
for prevention, including cardiovascular
disease, fragility fractures, renal and
hepatic disease, and cancers. The HOPS
remains an important source for multiyear trend data concerning conditions
and behaviors for which data are not
readily available elsewhere, including:
Rates of opportunistic illnesses, rates of
comorbid conditions (e.g., hypertension,
obesity, diabetes) and antiretroviral drug
resistance.
Data will be collected through
medical record abstraction by trained
abstractors and by telephone or internetbased, computer-assisted interviews at
nine funded study sites in six U.S.
cities. Collection of data abstracted from
patient medical records provides data in
five general categories: Demographics
and risk behaviors for HIV infection;
symptoms; diagnosed conditions
HIV-care at the nine aforementioned
clinics (50 patients per site). Patients are
approached during one of their routine
clinic visits to participate in the HOPS.
Patients interested in participating in
the HOPS are given detailed information
about the nature of the study and
provided with written informed consent
that must be completed prior to
enrollment.
The 450 newly enrolled participants
each year will be added to the database
of existing participants such that
approximately 2,500 participants will be
seen in the HOPS each year. Medical
record abstractions will be completed
on all HOPS participants, and impose
no direct burden on HOPS study
participants.
Participation of respondents is
voluntary. There is no cost to the
respondents other than their time.
(definitive and presumptive);
medications prescribed (including dose,
duration, and reasons for stopping); all
laboratory values, including CD4+ Tlymphocyte (CD4+) cell counts, plasma
HIV–RNA determinations, and
genotype, phenotype, and trophile
results. Data on visit frequency, AIDS,
and death are acquired from the clinic
chart.
Data collected using a brief Telephone
Audio-Computer Assisted SelfInterview (T–ACASI) survey or an
identical Web-based Audio-Computer
Assisted Self-Interview (ACASI)
include: Age, sex at birth, use of alcohol
and drugs, cigarette smoking, adherence
to antiretroviral medications, types of
sexual intercourse, condom use, and
disclosure of HIV status to partners.
We anticipate that 450 new HOPS
study participants will be recruited
annually into the HOPS from a pool of
HIV-infected individuals currently in
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
HOPS study Patients ........................
HOPS Study Patients .......................
Consent form ....................................
Behavioral survey .............................
450
2,500
1
1
15/60
7/60
113
292
Total ...........................................
...........................................................
........................
........................
........................
405
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–30889 Filed 1–5–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Number: 93.604]
Announcement of the Award of an
Urgent Single-Source Grant to the
Center for Survivors of Torture in
Dallas, TX.
Office of Refugee Resettlement,
ACF, HHS.
ACTION: Announcement of the award of
an urgent single-source grant to the
Center for Survivors of Torture to
provide mental health services for
victims of torture.
tkelley on DSK3SPTVN1PROD with NOTICES
AGENCY:
The Administration for
Children and Families (ACF), Office of
Refugee Resettlement (ORR) announces
SUMMARY:
VerDate Sep<11>2014
19:38 Jan 05, 2015
Jkt 235001
the award of an urgent single-source
grant in the amount of $250,000 to the
Center for Survivors of Torture (CST) in
Dallas, TX, to ensure incoming refugee
populations in Texas have access to
mental health services.
DATES: The project period for the award
is July 1, 2014 through September 29,
2015.
FOR FURTHER INFORMATION CONTACT:
Kenneth Tota, Deputy Director, Office of
Refugee Resettlement, 901 D. Street
SW., Washington, DC 20047. Telephone:
202–401–4858. Email: kenneth.tota@
acf.hhs.gov.
SUPPLEMENTARY INFORMATION: CST is the
only accredited mental health care
provider of specialized torture survivor
mental health treatment services in
Texas and the surrounding area. Many
refugees have been victims of torture.
Approximately 48,000 individual
refugees reside in the areas covered by
CST. Texas is a top resettlement
location with one of the highest
concentrations of refugees in the United
States. In the past few years, an
increasing need for mental health
services has been associated with
refugee populations from Iraq, Burma,
and Bhutan who have suffered trauma
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
and torture due to war and genocide in
those countries. Currently, the U.S.
refugee resettlement program is seeing a
rise in refugees from the Democratic
Republic of Congo (DRC). The United
Nations High Commissioner for
Refugees has determined this group is
particularly at risk due to decades of
extreme violence in DRC and recent
arrivals have shown a compelling need
for mental health services upon
resettlement.
CST services are critical to meeting
the mental health needs of individuals
who have survived torture. They
provide evaluation and counseling to
children, adolescents, adults, couples,
and families. Additionally, CST offers
group therapy, psychosocial activities,
and medication management. In
addition to these direct services, CST
also provides training on refugee mental
health issues to other organizations in
the area, including schools, health
clinics, and social services agencies.
During the period of April 1, 2013
through March 31, 2014, CST provided
free comprehensive mental health
services to 355 ORR clients. More than
82 percent of these clients experienced
a reduction in symptoms.
E:\FR\FM\06JAN1.SGM
06JAN1
]]>Agencies
[Federal Register Volume 80, Number 3 (Tuesday, January 6, 2015)]
[Notices]
[Pages 506-507]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-30889]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-15-15JX]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden and maximize the utility
of government information, invites the general public and other Federal
agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. To request more information on the below
proposed project or to obtain a copy of the information collection plan
and instruments, call 404-639-7570 or send comments to LeRoy
Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an
email to omb@cdc.gov.
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
HIV Outpatient Study (HOPS)--New--National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention requests a three-
year approval for the HIV Outpatient Study data collection activity.
The HIV Outpatient Study (HOPS) is a prospective longitudinal cohort of
HIV-infected outpatients at nine well-established private HIV care
practices and university-based U.S. clinics, in Tampa, Florida;
Washington, DC; Stony Brook, New York; Chicago, Illinois; Denver,
Colorado; and Philadelphia, Pennsylvania.
Clinical data are abstracted on ongoing basis from the medical
records of adult HIV-infected HOPS study participants, who also
complete an optional telephone/Web-based behavioral assessment as part
of their annual clinic visit, which on average takes about seven
minutes. Before enrolling in this study, all potential study
participants will undergo an informed consent process (including
signing of a written informed consent) which is estimated to take 15
minutes.
The core areas of HOPS research extending through the present HIV
treatment era include (i) monitoring death rates and causes of death,
(ii) characterizing the optimal patient management strategies to reduce
HIV-related morbidity and mortality (e.g., effectiveness of
antiretroviral therapies and other clinical interventions), (iii)
monitoring of sexual and drug use behaviors to inform Prevention with
Positives, and (iv) investigating disparities in the HIV care continuum
by various demographic factors. In recent years, the HOPS has been
[[Page 507]]
instrumental in bringing attention to emerging issues in chronic HIV
infection with actionable opportunities for prevention, including
cardiovascular disease, fragility fractures, renal and hepatic disease,
and cancers. The HOPS remains an important source for multi-year trend
data concerning conditions and behaviors for which data are not readily
available elsewhere, including: Rates of opportunistic illnesses, rates
of comorbid conditions (e.g., hypertension, obesity, diabetes) and
antiretroviral drug resistance.
Data will be collected through medical record abstraction by
trained abstractors and by telephone or internet-based, computer-
assisted interviews at nine funded study sites in six U.S. cities.
Collection of data abstracted from patient medical records provides
data in five general categories: Demographics and risk behaviors for
HIV infection; symptoms; diagnosed conditions (definitive and
presumptive); medications prescribed (including dose, duration, and
reasons for stopping); all laboratory values, including CD4+ T-
lymphocyte (CD4+) cell counts, plasma HIV-RNA determinations, and
genotype, phenotype, and trophile results. Data on visit frequency,
AIDS, and death are acquired from the clinic chart.
Data collected using a brief Telephone Audio-Computer Assisted
Self-Interview (T-ACASI) survey or an identical Web-based Audio-
Computer Assisted Self-Interview (ACASI) include: Age, sex at birth,
use of alcohol and drugs, cigarette smoking, adherence to
antiretroviral medications, types of sexual intercourse, condom use,
and disclosure of HIV status to partners.
We anticipate that 450 new HOPS study participants will be
recruited annually into the HOPS from a pool of HIV-infected
individuals currently in HIV-care at the nine aforementioned clinics
(50 patients per site). Patients are approached during one of their
routine clinic visits to participate in the HOPS. Patients interested
in participating in the HOPS are given detailed information about the
nature of the study and provided with written informed consent that
must be completed prior to enrollment.
The 450 newly enrolled participants each year will be added to the
database of existing participants such that approximately 2,500
participants will be seen in the HOPS each year. Medical record
abstractions will be completed on all HOPS participants, and impose no
direct burden on HOPS study participants.
Participation of respondents is voluntary. There is no cost to the
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
HOPS study Patients........... Consent form.... 450 1 15/60 113
HOPS Study Patients........... Behavioral 2,500 1 7/60 292
survey.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 405
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-30889 Filed 1-5-15; 8:45 am]
BILLING CODE 4163-18-P
